New research progress on application of sacubitril valsartan in cardiovascular diseases
LIU Juan-xia
SHI Liang
LIU Xiao-li
ZHANG Zhao-jie
MA Ling
SU Fang-ju
Abstract:Cardiovascular disease is a serious global public health challenge.Despite the many variety of medicines,the mortality remains high,and there is an urgent need to develop new drugs to improve patient outcomes.Sacubitril/valsartan,as a novel neuroendocrine inhibitor with highly selective inhibition of angiotensin receptor and neprilysin enzyme,has made significant progress in the treatment of cardiovascular diseases.This article reviews the application and mechanism of sacubitril/valsartan in the treatment of cardiovascular diseases.
Keywords:Sacubitril/valsartanCardiovascular diseaseClinical useMechanism of action
Publication Date:2025-08-20
Online Publishing Date:2025-09-05(First online date of this platform, not the publication date of the document)
Pages:6( 709-714 )
Chinese Journal of Cardiovascular Research

Chinese Journal of Cardiovascular Research

ISTIC
ISSN:1672-5301
Year, Vol.(Issue):2025,23(8)